- Home
- ARWR vs ESAB Comparison
ARWR vs ESAB Comparison
Compare ARWR & ESAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- ESAB
- Stock Information
- Founded
- ARWR 2003
- ESAB 1904
- Country
- ARWR United States
- ESAB United States
- Employees
- ARWR N/A
- ESAB N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- ESAB Office Equipment/Supplies/Services
- Sector
- ARWR Health Care
- ESAB Industrials
- Exchange
- ARWR Nasdaq
- ESAB Nasdaq
- Market Cap
- ARWR 5.9B
- ESAB 6.6B
- IPO Year
- ARWR 1993
- ESAB N/A
- Fundamental
- Price
- ARWR $40.96
- ESAB $114.83
- Analyst Decision
- ARWR Strong Buy
- ESAB Strong Buy
- Analyst Count
- ARWR 8
- ESAB 8
- Target Price
- ARWR $47.75
- ESAB $143.38
- AVG Volume (30 Days)
- ARWR 1.7M
- ESAB 493.5K
- Earning Date
- ARWR 11-25-2025
- ESAB 10-29-2025
- Dividend Yield
- ARWR N/A
- ESAB 0.35%
- EPS Growth
- ARWR N/A
- ESAB N/A
- EPS
- ARWR N/A
- ESAB 3.95
- Revenue
- ARWR $572,976,000.00
- ESAB $2,792,325,000.00
- Revenue This Year
- ARWR $21,287.22
- ESAB $3.25
- Revenue Next Year
- ARWR N/A
- ESAB $8.37
- P/E Ratio
- ARWR N/A
- ESAB $29.17
- Revenue Growth
- ARWR 2816.20
- ESAB 1.19
- 52 Week Low
- ARWR $9.57
- ESAB $100.17
- 52 Week High
- ARWR $43.69
- ESAB $135.85
- Technical
- Relative Strength Index (RSI)
- ARWR 60.87
- ESAB 47.15
- Support Level
- ARWR $37.35
- ESAB $110.98
- Resistance Level
- ARWR $42.00
- ESAB $116.42
- Average True Range (ATR)
- ARWR 2.18
- ESAB 3.61
- MACD
- ARWR -0.28
- ESAB -0.63
- Stochastic Oscillator
- ARWR 61.35
- ESAB 38.30
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.